These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 17400654)

  • 1. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.
    Mosig RA; Dowling O; DiFeo A; Ramirez MC; Parker IC; Abe E; Diouri J; Aqeel AA; Wylie JD; Oblander SA; Madri J; Bianco P; Apte SS; Zaidi M; Doty SB; Majeska RJ; Schaffler MB; Martignetti JA
    Hum Mol Genet; 2007 May; 16(9):1113-23. PubMed ID: 17400654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of MMP-2 in murine osteoblasts upregulates osteopontin and bone sialoprotein expression in a circuit regulating bone homeostasis.
    Mosig RA; Martignetti JA
    Dis Model Mech; 2013 Mar; 6(2):397-403. PubMed ID: 22917927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.
    Egeblad M; Shen HC; Behonick DJ; Wilmes L; Eichten A; Korets LV; Kheradmand F; Werb Z; Coussens LM
    Dev Dyn; 2007 Jun; 236(6):1683-93. PubMed ID: 17440987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
    Dai XM; Zong XH; Akhter MP; Stanley ER
    J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism.
    Inoue K; Mikuni-Takagaki Y; Oikawa K; Itoh T; Inada M; Noguchi T; Park JS; Onodera T; Krane SM; Noda M; Itohara S
    J Biol Chem; 2006 Nov; 281(44):33814-24. PubMed ID: 16959767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.
    Dvorak-Ewell MM; Chen TH; Liang N; Garvey C; Liu B; Tu C; Chang W; Bikle DD; Shoback DM
    J Bone Miner Res; 2011 Dec; 26(12):2935-47. PubMed ID: 21956637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
    Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
    Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
    Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
    J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtubule assembly affects bone mass by regulating both osteoblast and osteoclast functions: stathmin deficiency produces an osteopenic phenotype in mice.
    Liu H; Zhang R; Ko SY; Oyajobi BO; Papasian CJ; Deng HW; Zhang S; Zhao M
    J Bone Miner Res; 2011 Sep; 26(9):2052-67. PubMed ID: 21557310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.
    Thiolloy S; Edwards JR; Fingleton B; Rifkin DB; Matrisian LM; Lynch CC
    PLoS One; 2012; 7(1):e29862. PubMed ID: 22238668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.
    Martignetti JA; Aqeel AA; Sewairi WA; Boumah CE; Kambouris M; Mayouf SA; Sheth KV; Eid WA; Dowling O; Harris J; Glucksman MJ; Bahabri S; Meyer BF; Desnick RJ
    Nat Genet; 2001 Jul; 28(3):261-5. PubMed ID: 11431697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Al-Aqeel Sewairi syndrome, a new autosomal recessive disorder with multicentric osteolysis, nodulosis and arthropathy. The first genetic defect of matrix metalloproteinase 2 gene.
    Al-Aqeel AI
    Saudi Med J; 2005 Jan; 26(1):24-30. PubMed ID: 15756348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
    Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S
    J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis.
    Shimizu T; Takahata M; Kameda Y; Endo T; Hamano H; Hiratsuka S; Ota M; Iwasaki N
    Bone; 2015 Oct; 79():65-70. PubMed ID: 26027508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects.
    Tuysuz B; Mosig R; Altun G; Sancak S; Glucksman MJ; Martignetti JA
    Eur J Hum Genet; 2009 May; 17(5):565-72. PubMed ID: 18985071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional Deletion of Indian Hedgehog in Limb Mesenchyme Results in Complete Loss of Growth Plate Formation but Allows Mature Osteoblast Differentiation.
    Amano K; Densmore MJ; Lanske B
    J Bone Miner Res; 2015 Dec; 30(12):2262-72. PubMed ID: 26094741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.
    Subramaniam M; Gorny G; Johnsen SA; Monroe DG; Evans GL; Fraser DG; Rickard DJ; Rasmussen K; van Deursen JM; Turner RT; Oursler MJ; Spelsberg TC
    Mol Cell Biol; 2005 Feb; 25(3):1191-9. PubMed ID: 15657444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism.
    Bassett JH; Williams AJ; Murphy E; Boyde A; Howell PG; Swinhoe R; Archanco M; Flamant F; Samarut J; Costagliola S; Vassart G; Weiss RE; Refetoff S; Williams GR
    Mol Endocrinol; 2008 Feb; 22(2):501-12. PubMed ID: 17932107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.